Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial - PubMed

Jewish General Hospital (Astellas Canada).
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov